Health Care Facilities

Raffles Medical

Raffles Medical Group Releases 2025 Annual Report, Emphasizing Stable Performance and Expansion Plans

Raffles Medical Group's Chairman Lo Kwan Yung Acquires 128,800 Shares

Raffles Medical released FY2025 9 Months Earnings on February 22, 2026, during market hours (SGT), with actual revenue of SGD 574.66 M and actual EPS of SGD 0.0276

Raffles Medical released FY2025 Q3 earnings on February 22, 2026 (SGT) with actual revenue of SGD 193.56 M and EPS of SGD 0.0104

Raffles Medical released FY2025 Annual Earnings on February 22 Pre-Market (SGT), actual revenue SGD 765.57 M (forecast SGD 784.28 M), actual EPS SGD 0.038 (forecast SGD 0.0368)

Raffles Medical released FY2025 Q4 earnings on February 22 Pre-Market (SGT), actual revenue SGD 193.56 M, actual EPS SGD 0.0104

Raffles Medical to Release FY2025 Earnings on February 23, 2026, Pre-Market SGT; Forecast Revenue SGD 784.28 M, EPS SGD 0.0368

Raffles Medical Group Reports Earnings and Advances Sino-New Medical Cooperation

Raffles Medical released FY2025 Q1 earnings on July 27, 2025 (SGT) with actual revenue of SGD 189.22 M and EPS of SGD 0.0086

Raffles Medical released FY2025 Q2 earnings on July 27 Pre-Market SGT, actual revenue SGD 189.22 M, actual EPS SGD 0.0086

Raffles Medical released FY2025 Semi-Annual earnings on July 27 Pre-Market SGT, actual revenue SGD 378.45 M, actual EPS SGD 0.0172

Raffles Medical to Release FY2025 Semi-Annual Earnings on July 28, 2025 (SGT)

UOB Research Recommends Buying Raffles Medical Stocks

Insiders at Raffles Medical Group Net Buy Stocks

Raffles Medical and Renji Hospital Reach Agreement to Establish 'Dual Circulation' Medical Resource Service System

Raffles Medical Group repurchases 141,600 shares of stock for a total of SGD 141,076

Raffles Medical Exercises Stock Options, Reducing Treasury Shares to 31.1 Million

Raffles Medical released FY2024 Q3 earnings on February 23, 2025 (SGT), actual revenue SGD 193.37 M, actual EPS SGD 0.0084

Raffles Medical released FY2024 9 Months Earnings on February 23, 2025 (SGT) with actual revenue of SGD 559.06 M and actual EPS of SGD 0.0246

Raffles Medical released FY2024 Q4 earnings on February 23 Pre-Market (SGT), actual revenue SGD 193.37 M, actual EPS SGD 0.0084

SingtelMBeCW260730

Abundance

Geely MB ePW261005

Asiatic

HSI 28000MBePW260629

Alibaba MB eCW260703

Teho

Acesian Partners

NKY 55000MBePW260911

NKY 52000MBePW260612

HSBC

HSBH

HSBC Singapore has introduced new health and wellness benefits for its Premier clients, including access to IHH Healthcare's Parkway Shenton app and Raffles Medical's MediWellness facilities. Clients will enjoy priority access to health services, 24/7 concierge support, health screening packages, and personalized health management plans. The initiative reflects a growing trend among clients to prioritize health and wellness alongside financial wealth, with a noted 35% increase in health-related transactions on HSBC credit cards over the past five years.

Singapore Business Review

HSBC Holdings plc ADRhedged

HSBC HOLDINGS

HSBC Holdings Plc

HSBC 5xShortSG241213

HSBC Singapore adds health perks for Premier clients via IHH, Raffles Medical

Raffles Medical Group stated at the shareholders' meeting that its performance in China has been poor and requires more time to achieve significant returns. Although the China business accounts for 30% of the group's assets, it only contributes 10% of the revenue. The group pointed out that overseas investments typically take longer to scale and establish clinical capabilities, and the Chinese market is constrained by geopolitical and technological challenges. The Securities and Futures Commission believes that the China business has only increased revenue by approximately 25.4 million yuan over the past seven years, and it is expected to reach 65.4 million yuan by the fiscal year 2025

Zaobao

Raffles Medical: More time needed to generate strong returns due to poor performance in China | Lianhe Zaobao

Raffles Medical Group's China business, which constitutes 30% of its assets, generates only 10% of its revenue. The group acknowledged that overseas investments take time to develop scale and patient volumes. Despite a slow revenue increase to S$65.4 million in FY2025, the board emphasized the importance of the Chinese market, noting geopolitical and technological challenges. They are focusing on operational efficiency and increasing local service access, having secured local government insurance. Raffles Medical's stock closed at S$1.02, down 1% on Friday.

Businesstimes News

Raffles Medical’s China business is underperforming but group says time is needed to deliver

02378

Five out of seven Integrated Shield Plan (IP) insurers in Singapore are increasing premiums for base plans, particularly for private hospitals and Class-A wards. This comes despite new riders being 30% cheaper than older ones. Insurers like Prudential, HSBC Life, and Raffles Health Insurance are raising premiums due to medical inflation and rising healthcare costs. The average medical inflation rate is projected at 16.9% for 2026. The changes aim to curb excessive claims and encourage policyholders to participate in healthcare pricing discussions.

Prudential USD

Some IP insurers hike premiums of base plans for private hospital and A-class wards

Dr. Loo Choon Yong, CEO of Raffles Medical Group Ltd, has increased his stake in the company by purchasing 159,100 shares at $0.99 each, raising his total interest to 56.29%. This acquisition brings his direct shareholding to 251.92 million shares, which is 13.69% of the total ordinary voting shares. His deemed interest includes shares held through Raffles Medical Holdings Pte Ltd, where he is a director and shareholder.

Raffles Medical CEO tightens grip with $0.99 share sweep

For the period from February 27 to March 5, Singapore experienced a net institutional outflow of S$41 million, totaling S$148 million for Q1 2026. Notable stocks with high outflows included DBS Group and Sembcorp Industries, while Singapore Airlines and UOB-Kay Hian saw inflows. During this time, 26 companies executed buybacks totaling S$131 million, led by Singapore Telecommunications. Additionally, over 130 director transactions were reported, with significant acquisitions from Centurion Corporation and Raffles Medical Group, reflecting positive earnings momentum and shareholder commitment.

Sembcorp Ind

SingTel

DBS Group

UOB Kay Hian

Singtel

Centurion

Buybacks & Director Filings Surge Following Heavy Earnings Season

Raffles Medical Group (SGX:BSL) reported strong 2025 results and proposed a final dividend of 3.0 Singapore cents per share, pending shareholder approval. The stock has shown a 3.5% return over the past month but a 17.2% decline over three years. With a P/E ratio of 26.9x, it is considered undervalued compared to peers but expensive against the broader Asian healthcare average. A DCF model suggests a potential upside to S$1.94, indicating possible growth. Investors are advised to weigh risks and explore other healthcare stocks for opportunities.

Simplywall

Assessing Raffles Medical Group (SGX:BSL) Valuation After Strong 2025 Results And Proposed Final Dividend

For the trading sessions from Feb 27 to Mar 5, Singapore saw a net institutional outflow of S$41 million, totaling S$148 million for Q1 2026. Notable outflows were from DBS and Sembcorp Industries, while Singapore Airlines and OCBC led inflows. During this period, 26 companies executed buybacks totaling S$131 million, with Singtel leading. Over 130 director transactions were reported, including significant acquisitions by Centurion's CEO and Raffles Medical's chairman. Centurion's FY25 net profit rose 26%, while Raffles Medical's profit increased 13.4%.

OCBC Bank

Buybacks and director filings surge following heavy earnings season

[SINGAPORE] For five decades, Raffles Medical Group (RMG) has been the reliable – if somewhat staid – pulse of Singapore’s private healthcare sector. The critiques have been as consistent as its sterile hallways: too slow, too cautious, and too bogged down by the “gestational losses” of its ambitious China expansion. And as the group enters its golden jubilee, executive chairman Dr Loo Choon Yong is doubling down on his “long-term play” philosophy.

As Raffles Medical celebrates its golden jubilee, the doctor calls for more patience

Raffles Medical(BSL.SG)